A One-Year Study To Evaluate The Effects And Safety Of CP-690,550 In Patients With Moderate To Severe Chronic Plaque Psoriasis
Clinical trial NCT01276639 · COMPLETED
Trial details
- NCT number
- NCT01276639
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-03-01
- Primary completion
- 2013-04-01
- Enrollment
- 901
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.